Gene · 5068
Papers2,978
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,978
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of a robust inflammation-related three-gene signature for the diagnosis of neonatal necrotizing enterocolitis via machine learning integration. | Pediatr Surg Int | 2026 | 42799867 | PubTator, text mining | PubMed |
| Primary Neoplasms of the Seminal Vesicles: A Narrative Review of Carcinoma and the Rarer Non-Epithelial and Biphasic Tumours. | Diagnostics (Basel) | 2026 | 42793728 | PubTator, text mining | PubMed |
| Regenerating Islet-Derived 3α Is a Predictive Biomarker of Complicated Disease From Preclinical Through Established Crohn's Disease. | Clin Gastroenterol Hepatol | 2026 | 42685961 | PubTator, text mining | PubMed |
| Second-line and salvage therapies for steroid-refractory acute graft-versus-host disease: an integrated synthesis of current evidence and clinical sequencing. | Curr Opin Hematol | 2026 | 42673530 | PubTator, text mining | PubMed |
| Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation. | Curr Opin Hematol | 2026 | 42673525 | PubTator, text mining | PubMed |
| An axon-intrinsic loop restricts nerve regeneration through axonal protein synthesis. | Sci Adv | 2026 | 42647628 | PubTator, text mining | PubMed |
| Human milk oligosaccharide (2'-FL) modifies the gut microbiome in children after bone marrow transplant. | Blood | 2026 | 42622257 | PubTator, text mining | PubMed |
| Revised porcine IgG subclass classification based on innate immune cell activation. | Front Immunol | 2026 | 42602303 | PubTator, text mining | PubMed |
| Association between gut epithelial barrier biomarkers and LDL-cholesterol in HIV-infected individuals. | Medicine (Baltimore) | 2026 | 42601778 | PubTator, text mining | PubMed |
| [The Impact of Nutritional Intervention on Complications and Prognosis of Hematopoietic Stem Cell Transplantation Patients]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544681 | PubTator, text mining | PubMed |
| Serum REG3α as a biomarker for clinical and endoscopic activity in ulcerative colitis. | Sci Rep | 2026 | 42414497 | PubTator, text mining | PubMed |
| TRPML1 positions lysosomes and regulates actin-membrane linkers in astrocyte processes. | bioRxiv | 2026 | 42395471 | PubTator, text mining | PubMed |
| Development and Validation of a Cytokine-Based Predictive Model for Acute GvHD and Composite Outcomes in ATG-Based Haploidentical Hematopoietic Stem Cell Transplantation. | Mediators Inflamm | 2026 | 42377328 | PubTator, text mining | PubMed |
| Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresis. | Front Immunol | 2026 | 42375383 | PubTator, text mining | PubMed |
| Advances in graft-versus-host disease: emerging therapeutic strategies, biomarker discoveries, and innovative treatment approaches. | Front Immunol | 2026 | 42367753 | PubTator, text mining | PubMed |
| REG3A: A Potential Fecal Biomarker for Ulcerative Colitis. | Mediators Inflamm | 2026 | 42345560 | PubTator, text mining | PubMed |
| Dynamic immune profiling enables early distinction between gastrointestinal GVHD and viral diarrhea after hematopoietic stem cell transplantation. | BMC Immunol | 2026 | 42185760 | PubTator, text mining | PubMed |
| Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM. | Blood Immunol Cell Ther | 2026 | 42137422 | PubTator, text mining | PubMed |
| Integrated Inflammatory Biomarker Profiling Differentiates Degrees of Body Mass Index Beyond Intestinal Barrier-Related Markers. | Cells | 2026 | 42121864 | PubTator, text mining | PubMed |
| Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation. | Br J Haematol | 2026 | 42047487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5068/papers